Source: FinanzNachrichten

Nicox: NICOX SA: Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights

Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Last patient recruited in the NCX 470 (bimatoprost grenod) Phase 3 Denali clinical trial with topline resul...

Read full article »
Nicox's Competitors | Nicox's News | Nicox's Financials
Stay up-to-date with the latest news on Nicox
Annual Revenue
$5.0-25M
Employees
1-25
Gavin Spencer's photo - CEO of Nicox

CEO

Gavin Spencer

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Nicox